Ascorbic acid increases cardiovagal baroreflex sensitivity in healthy older men

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 6 55-6, 2004, Pages

  Monahan, Kevin D ^a,c   Eskurza, Iratxe ^a   Seals, Douglas R ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Baroreceptors; Blood pressure

Indexed keywords

ASCORBIC ACID; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ADULT; AGE DISTRIBUTION; AGED; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY; DRUG BLOOD LEVEL; ELDERLY CARE; HEART MUSCLE; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RR INTERVAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; VAGUS REFLEX;

ADULT; AGED; AGING; ANTIOXIDANTS; ASCORBIC ACID; BAROREFLEX; HEART; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OXIDATIVE STRESS; VAGUS NERVE;

EID: 2542478969     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01054.2003     Document Type: Article

References (42)

1. Agus DB, Gambhir SS, Pardridge WM, Spielholz C, Baselga J, Vera JC, and Golde DW. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest 100: 2842-2848, 1997.
2. Bristow JD, Gribbin B, Honour AJ, Pickering TG, and Sleight P. Diminished baroreflex sensitivity in high blood pressure and ageing man. J Physiol 202: 45P-46P, 1969.
3. Bristow JD, Honour AJ, Pickering GW, Sleight P, and Smyth HS. Diminished baroreflex sensitivity in high blood pressure. Circulation 39: 48-54, 1969.
4. Chapleau MW, Li Z, Meyrelles SS, Ma X, and Abboud FM. Mechanisms determining sensitivity of baroreceptor afferents in health and disease. Ann NY Acad Sci 940: 1-19, 2001.
5. Chowdhary S, Andre Ng G, Nuttall SL, Coote JH, Ross HF, and Townend JN. Nitric oxide and cardiac parasympathetic control in human heart failure. Clin Sci (Lond) 102: 397-402, 2002.
6. Chowdhary S and Townend JN. Role of nitric oxide in the regulation of cardiovascular autonomic control. Clin Sci (Lond) 97: 5-17, 1999.
7. Chowdhary S, Vaile JC, Fletcher J, Ross HF, Coote JH, and Townend JN. Nitric oxide and cardiac autonomic control in humans. Hypertension 36: 264-269, 2000.
8. Ebert TJ and Cowley AW Jr. Baroreflex modulation of sympathetic outflow during physiological increases of vasopressin in humans. Am J Physiol Heart Circ Physiol 262: H1372-H1378, 1992.
9. Ebert TJ, Morgan BJ, Barney JA, Denahan T, and Smith JJ. Effects of aging on baroreflex regulation of sympathetic activity in humans. Am J Physiol Heart Circ Physiol 263: H798-H803, 1992.
10. Eckberg DL and Sleight P. Human Baroreflexes in Health and Disease. Oxford, UK: Clarendon, 1992.
11. Frei B, England L, and Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86: 6377-6381, 1989.
12. Gilman JK, Jalal S, and Naccarelli GV. Predicting and preventing sudden death from cardiac causes. Circulation 90: 1083-1092, 1994.
13. Gribbin B, Pickering TG, Sleight P, and Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 29: 424-431, 1971.
14. Halliwill JR and Minson CT. Effect of hypoxia on arterial baroreflex control of heart rate and muscle sympathetic nerve activity in humans. J Appl Physiol 93: 857-864, 2002.
15. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, and Dominiczak AF. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37: 529-534, 2001.
16. Jackson TS, Xu A, Vita JA, and Keaney JF Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83: 916-922, 1998.
17. Kasapoglu M and Ozben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Gerontol 36: 209-220, 2001.
18. Knight JA. The biochemistry of aging. Adv Clin Chem 35: 1-62, 2000.
19. La Rovere MT, Bigger JT, Marcus FI, Mortara A, and Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351: 478-484, 1998.
20. La Rovere TM, Specchia G, Mortara A, and Schwartz PJ. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction: a prospective study. Circulation 78: 816-824, 1988.
21. Lakatta EG and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a "set up" for vascular disease. Circulation 107: 139-146, 2003.
22. Li Z, Mao HZ, Abboud FM, and Chapleau MW. Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ Res 79: 802-811, 1996.
23. Ma S, Abboud FM, and Felder RB. Effects of 1-arginine-derived nitric oxide synthesis on neuronal activity in nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 268: R487-R491, 1995.
24. Monahan KD, Dinenno FA, Seals DR, Clevenger CM, DeSouza CA, and Tanaka H. Age-associated changes in cardiovagal baroreflex sensitivity are related to central arterial compliance. Am J Physiol Heart Circ Physiol 281: H284-H289, 2001.
25. Monahan KD, Dinenno FA, Tanaka H, Clevenger CM, DeSouza CA, and Seals DR. Regular aerobic exercise modulates age-associated declines in cardiovagal baroreflex sensitivity in healthy men. J Physiol 529, Pt 1: 263-271, 2000.
26. Monahan KD, Tanaka H, Dinenno FA, and Seals DR. Central arterial compliance is associated with age- and habitual exercise-related differences in cardiovagal baroreflex sensitivity. Circulation 104: 1627-1632, 2001.
27. Nightingale AK, Blackman DJ, Field R, Glover NJ, Pegge N, Mumford C, Schmitt M, Ellis GR, Morris-Thurgood JA, and Frenneaux MP. Role of nitric oxide and oxidative stress in baroreceptor dysfunction in patients with chronic heart failure. Clin Sci (Lond) 104: 529-535, 2003.
28. Piccirillo G, Nocco M, Moise A, Lionetti M, Naso C, di Carlo S, and Marigliano V. Influence of vitamin C on baroreflex sensitivity in chronic heart failure. Hypertension 41: 1240-1245, 2003.
29. Rubanyi GM and Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 250: H822-H827, 1986.
30. Rudas L, Crossman AA, Morillo CA, Halliwill JR, Tahvanainen KU, Kuusela TA, and Eckberg DL. Human sympathetic and vagal baroreflex responses to sequential nitroprusside and phenylephrine. Am J Physiol Heart Circ Physiol 276: H1691-H1698, 1999.
31. Sherman DL, Keaney JF Jr, Biegelsen ES, Duffy SJ, Coffman JD, and Vita JA. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 35: 936-941, 2000.
32. Shi X, Walter DW, Formes KJ, Wang HW, Hayes PM, OYurvati AH, Weiss MS, and Reese IP. Orthostatic hypotension in aging humans. Am J Physiol Heart Circ Physiol 279: H1548-H1554, 2000.
33. Smyth HS, Sleight P, and Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res 24: 109-121, 1969.
34. Spector R. Vitamin homeostasis in the central nervous system. N Engl J Med 296: 1393-1398, 1977.
35. Spieker LE, Corti R, Binggeli C, Luscher TF, and Noll G. Baroreceptor dysfunction induced by nitric oxide synthase inhibition in humans. J Am Coll Cardiol 36: 213-218, 2000.
36. Stevenson ET, Davy KP, and Seals DR. Maximal aerobic capacity and total blood volume in highly trained middle-aged and older female endurance athletes. J Appl Physiol 77: 1691-1696, 1994.
37. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, and Salvetti A. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38: 274-279, 2001.
38. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I, and Salvetti A. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91: 1981-1987, 1995.
39. Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA, and Seals DR. Aging, habitual exercise, and dynamic arterial compliance. Circulation 102: 1270-1275, 2000.
40. Van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palaclos-Callender M, Erusalimsky JD, Quaschning T, Malinski T, Gygi D, Ullrich V, and Luscher TF. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 192: 1731-1744, 2000.
41. Van Merode T, Hick PJ, Hoeks AP, Rahn KH, and Reneman RS. Carotid artery wall properties in normotensive and borderline hypertensive subjects of various ages. Ultrasound Med Biol 14: 563-569, 1988.
42. Zanzinger J, Czachurski J, and Seller H. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Am J Physiol Regul Integr Comp Physiol 268: R958-R962, 1995.